MLL-r Leukemia

Mixed lineage leukemia-1 (MLL-1) is a particular type of acute leukemia from the mutation of the MLL/KMT2A gene. This mutation can be seen in pediatrics, adults and therapy-induced acute leukemia’s. Discover the latest research on MLL-r leukemia here.

October 2, 2020

Bispecific antibodies in acute lymphoblastic leukemia therapy

Expert Review of Hematology
Chitadze GurandaBrüggemann Monika
September 29, 2020

ALL in adult patients: Contribution and limits of pediatric management

Bulletin du cancer
Florence Rabian, Nicolas Boissel
October 6, 2020

Treatment and outcome of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults after relapse

Expert Review of Anticancer Therapy
Marie BalsatXavier Thomas
October 14, 2020
Open Access

Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia

Medical Oncology
Mohadese Hashem BoroojerdiPooria Safarzadeh Kozani
October 8, 2020
Open Access

Application of Chromosome Conformation Capture Method for Detection MYC/TRD Chromosomal Translocation in Leukemia Cell Line

International Journal of Hematology-oncology and Stem Cell Research
Moloud AbsalanGholamreza Tavoosidana
September 30, 2020

First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia

Cancer Genetics
Sneha TandonOussama Abla
October 4, 2020

LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway

Pathology, Research and Practice
Yun-Ya LuoYun-Xiao Xu
October 3, 2020
Open Access

EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism

Genes & Development
Senthilkumar RamamoorthyRudolf Grosschedl
September 29, 2020

Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugate in Oncohematology

Recent Patents on Anti-cancer Drug Discovery
Romeo G Mihăilă
October 4, 2020

Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia

Pediatric Blood & Cancer
Amy MoskopRachel Phelan
October 13, 2020

Expanding the phenotype of Wiedemann-Steiner syndrome: Craniovertebral junction anomalies

American Journal of Medical Genetics. Part a
Sara GiangiobbeLivia Garavelli
October 1, 2020
Open Access

Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia

Cell Reports
Ryo MiyamotoAkihiko Yokoyama
October 11, 2020
Open Access

CSF-1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression

Journal of Cellular and Molecular Medicine
Kun LiXiaoyan Wu

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Antisense Oligonucleotide Therapies - ND and ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

© 2020 Meta ULC. All rights reserved